RS Sandler, NL Zorich, TG Filloon, HB … - Ann Intern Med, 1999 - Am Coll Physicians O lestra is an energy-free fat substitute approved by the US Food and Drug
Administration for use in snack foods, including potato chips, corn chips, and
crackers (1). Olestra, a mixture of su- crose esters of long-chain fatty ... Cited by 20 - Related articles - All 8 versions
LJ Cheskin, R Miday, N Zorich, T Filloon - JAMA, 1998 - Am Med Assoc You are seeing this message because your Web browser does not support basic Web
standards. Find out more about why this message is appearing and what you can do
to make your experience on this site better. ... Context.— Olestra, a ... Cited by 33 - Related articles - BL Direct - All 6 versions
NL Zorich, D Biedermann, KA Riccardi, LJ … - Regulatory Toxicology and Pharmacology, 1997 - Elsevier Olestra is a zero-calorie fat substitute that is neither digested nor absorbed.
A randomized, double-blind, placebo-controlled, within-subject, crossover
rechallenge study was conducted to compare the occurrence of ... Cited by 15 - Related articles - BL Direct - All 6 versions
J McRorie, N Zorich, K Riccardi, L Bishop, T … - Regulatory Toxicology and Pharmacology, 2000 - Elsevier The aim of this study was to determine the effects of olestra and sorbitol
consumption on three accepted objective measures of diarrhea (stool output >250
g/day, liquid/watery stools, bowel movement frequency >3/day), and how ... Cited by 18 - Related articles - BL Direct - All 6 versions
J McRorie, J Kesler, L Bishop, T Filloon, G … - The American journal of gastroenterology, 2000 - nature.com Compared with placebo, consumption of 20 g/day wheat bran for 6 days resulted in
a rapid (within 38 h) increase in mean ( SE) stool output (placebo, 150 29
g/day; bran, 246 35 g/day, p < 0.05), a directional increase in mean stool ... Cited by 10 - Related articles - BL Direct - All 8 versions
M Nestle - Public Health Reports (1974-), 1998 - jstor.org This Product Contains Olestra Olestra may cause ... SYN 0 PSIS THE PROCTER &
GAMBLE Company spent 30 years and an estimated $500 million to bring its
non-digestible fat substitute, olestra, to market. The Food and Drug ... Cited by 6 - Related articles - All 7 versions
BGV Meerveld, DE Neeley, KR Tyler, LJ … - Digestive diseases and sciences, 1999 - Springer The goal of this study was to compare the stool-softening effects of olestra and
wheat bran and to determine if changes in patterns of propagating colonic
motility were associated with the observed stool softening. Mini-pigs were ... Cited by 6 - Related articles - BL Direct - All 5 versions
- ►jmu.edu [DOC] JW Freston, DJ Ahnen, SJ Czinn, DL Earnest, … - Regulatory Toxicology and Pharmacology, 1997 - Elsevier Olestra, a dietary fat substitute, was recently made available to consumers in
savory snacks in three cities. Early reports of gastrointestinal complaints
attributed to olestra attracted media coverage and fostered confusion among ... Cited by 17 - Related articles - BL Direct - All 8 versions
RE Patterson, AR Kristal, JC Peters, ML … - Archives of Internal Medicine, 2000 - Am Med Assoc Methods This study examines the association of olestra consumption with changes
in dietary intakes of energy, fat, and cholesterol and changes in weight and
serum lipid concentrations. Data are from a cohort of 335 participants in ... Cited by 19 - Related articles - BL Direct - All 8 versions
